Drug company GlaxoSmithKline has confirmed that it will build a manufacturing facility in Ulverston, Cumbria, as part of a £500 million investment pledge for UK manufacturing.
The site will be the company’s first UK manufacturing facility in nearly 40 years.
This article is only available to Research Professional News subscribers or Pivot-RP users.
If you are a Research Professional News subscriber you can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.